Metraipolis › archive › dc_f1edd3bf879c
Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation — Europe PMC PMID:41900810
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41900810
- DOI
- 10.3390/pharmaceutics18030324
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T04:12:02.219Z
- SHA-256 of the archived text
b9c07fece37b935ad2d050f53bb8315006cb5296dc8b266cf65cd739ad701636- Stable URL of this page
https://metraipolis.com/documento/dc_f1edd3bf879c
How to cite
Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation — Europe PMC PMID:41900810 — Europe PMC (en), https://europepmc.org/article/MED/41900810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1edd3bf879c (Metraipolis archive dc_f1edd3bf879c, sha256 b9c07fece37b935ad2d050f53bb8315006cb5296dc8b266cf65cd739ad701636)
BibTeX
@misc{dcf1edd3bf879c,
title = {Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation — Europe PMC PMID:41900810},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41900810},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1edd3bf879c; sha256 b9c07fece37b935ad2d050f53bb8315006cb5296dc8b266cf65cd739ad701636},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41900810. Agents can read the archived copy with the MCP tool read_document.